# FDA advisory panel narrowly rejects compounding of one peptide, backs two others - STAT

*Источник: STAT*
*Дата: 2026-07-24*
*Язык: en*

<a href="https://news.google.com/rss/articles/CBMiogFBVV95cUxQMGhQZ0lpTHpic0VKbndwZjR6cnJNeEVTaGQyLURIZ3dIUDg5MWNsN21TQk1xTk5CTVgwV20xVnBFUHRjX3JUajdTMkI0bnU3QUlWVVBiNFgzU2pCQy12ODBzQzlPUUF3cExyTUlBOVVubk1nVnNsbk9CSUMtNWtqZ3QyRnllRFEzaWxBSzB4OUJwWHNKTmswU016NElNZFpUdnc?oc=5" target="_blank">FDA advisory panel narrowly rejects compounding of one peptide, backs two others</a>&nbsp;&nbsp;<font color="#6f6f6f">STAT</font>

[Оригинал](https://www.statnews.com/2026/07/24/fda-peptide-compounding-panel-backs-epitalon-rejects-emideltide/)